Cargando…

Pharmacoepidemiological Analysis of Oral Contraceptive Use in Adolescents in a German Longitudinal Cohort Study

To assess the use of oral contraceptives (OC) in adolescents, using data from a longitudinal, population-based pediatric cohort study (LIFE Child). We also investigated associations between OC use and socioeconomic status (SES), and associations between OC use and potential adverse drug reactions su...

Descripción completa

Detalles Bibliográficos
Autores principales: Herzig, Markus, Bertsche, Astrid, Hilbert, Cornelia, Kiess, Wieland, Bertsche, Thilo, Neininger, Martina Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955156/
https://www.ncbi.nlm.nih.gov/pubmed/36832522
http://dx.doi.org/10.3390/children10020393
_version_ 1784894286427324416
author Herzig, Markus
Bertsche, Astrid
Hilbert, Cornelia
Kiess, Wieland
Bertsche, Thilo
Neininger, Martina Patrizia
author_facet Herzig, Markus
Bertsche, Astrid
Hilbert, Cornelia
Kiess, Wieland
Bertsche, Thilo
Neininger, Martina Patrizia
author_sort Herzig, Markus
collection PubMed
description To assess the use of oral contraceptives (OC) in adolescents, using data from a longitudinal, population-based pediatric cohort study (LIFE Child). We also investigated associations between OC use and socioeconomic status (SES), and associations between OC use and potential adverse drug reactions such as effects on blood pressure. We included 609 female participants of the LIFE Child cohort, aged ≥13 to <21 years, who visited the study center between 2012 and 2019. Data collection compromised drug use in the past 14 days, SES, and anthropometric data such as blood pressure. An analysis of covariance was used to detect potential associations between participants’ blood pressure and OC. Multivariate binary logistic regression was used to obtain odds ratios (aOR) adjusted for age and 95% confidence intervals (95% CI). The prevalence of OC use was 25.8%. OC intake was less common in participants with a high SES (aOR 0.30, 95% CI 0.15, 0.62). The mean age at OC initiation did not change between 2012 and 2019. We observed an increased use of second-generation OC (2013: 17.9%, 2019: 48.5%; p = 0.013) and a decreased use of fourth-generation OC (2013: 71.8%, 2019: 45.5%; p = 0.027). We found a higher systolic (mean: 111.74 mmHg, p < 0.001) and diastolic (69.15 mmHg, p = 0.004) blood pressure in OC users compared to non-users (systolic: 108.60 mmHg; diastolic: 67.24 mmHg). Every fourth adolescent took an OC. The share of second-generation OC increased during the study period. OC intake was associated with low SES. OC users had a slightly higher blood pressure than non-users.
format Online
Article
Text
id pubmed-9955156
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99551562023-02-25 Pharmacoepidemiological Analysis of Oral Contraceptive Use in Adolescents in a German Longitudinal Cohort Study Herzig, Markus Bertsche, Astrid Hilbert, Cornelia Kiess, Wieland Bertsche, Thilo Neininger, Martina Patrizia Children (Basel) Article To assess the use of oral contraceptives (OC) in adolescents, using data from a longitudinal, population-based pediatric cohort study (LIFE Child). We also investigated associations between OC use and socioeconomic status (SES), and associations between OC use and potential adverse drug reactions such as effects on blood pressure. We included 609 female participants of the LIFE Child cohort, aged ≥13 to <21 years, who visited the study center between 2012 and 2019. Data collection compromised drug use in the past 14 days, SES, and anthropometric data such as blood pressure. An analysis of covariance was used to detect potential associations between participants’ blood pressure and OC. Multivariate binary logistic regression was used to obtain odds ratios (aOR) adjusted for age and 95% confidence intervals (95% CI). The prevalence of OC use was 25.8%. OC intake was less common in participants with a high SES (aOR 0.30, 95% CI 0.15, 0.62). The mean age at OC initiation did not change between 2012 and 2019. We observed an increased use of second-generation OC (2013: 17.9%, 2019: 48.5%; p = 0.013) and a decreased use of fourth-generation OC (2013: 71.8%, 2019: 45.5%; p = 0.027). We found a higher systolic (mean: 111.74 mmHg, p < 0.001) and diastolic (69.15 mmHg, p = 0.004) blood pressure in OC users compared to non-users (systolic: 108.60 mmHg; diastolic: 67.24 mmHg). Every fourth adolescent took an OC. The share of second-generation OC increased during the study period. OC intake was associated with low SES. OC users had a slightly higher blood pressure than non-users. MDPI 2023-02-16 /pmc/articles/PMC9955156/ /pubmed/36832522 http://dx.doi.org/10.3390/children10020393 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Herzig, Markus
Bertsche, Astrid
Hilbert, Cornelia
Kiess, Wieland
Bertsche, Thilo
Neininger, Martina Patrizia
Pharmacoepidemiological Analysis of Oral Contraceptive Use in Adolescents in a German Longitudinal Cohort Study
title Pharmacoepidemiological Analysis of Oral Contraceptive Use in Adolescents in a German Longitudinal Cohort Study
title_full Pharmacoepidemiological Analysis of Oral Contraceptive Use in Adolescents in a German Longitudinal Cohort Study
title_fullStr Pharmacoepidemiological Analysis of Oral Contraceptive Use in Adolescents in a German Longitudinal Cohort Study
title_full_unstemmed Pharmacoepidemiological Analysis of Oral Contraceptive Use in Adolescents in a German Longitudinal Cohort Study
title_short Pharmacoepidemiological Analysis of Oral Contraceptive Use in Adolescents in a German Longitudinal Cohort Study
title_sort pharmacoepidemiological analysis of oral contraceptive use in adolescents in a german longitudinal cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955156/
https://www.ncbi.nlm.nih.gov/pubmed/36832522
http://dx.doi.org/10.3390/children10020393
work_keys_str_mv AT herzigmarkus pharmacoepidemiologicalanalysisoforalcontraceptiveuseinadolescentsinagermanlongitudinalcohortstudy
AT bertscheastrid pharmacoepidemiologicalanalysisoforalcontraceptiveuseinadolescentsinagermanlongitudinalcohortstudy
AT hilbertcornelia pharmacoepidemiologicalanalysisoforalcontraceptiveuseinadolescentsinagermanlongitudinalcohortstudy
AT kiesswieland pharmacoepidemiologicalanalysisoforalcontraceptiveuseinadolescentsinagermanlongitudinalcohortstudy
AT bertschethilo pharmacoepidemiologicalanalysisoforalcontraceptiveuseinadolescentsinagermanlongitudinalcohortstudy
AT neiningermartinapatrizia pharmacoepidemiologicalanalysisoforalcontraceptiveuseinadolescentsinagermanlongitudinalcohortstudy